Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail

v3.8.0.1
Consolidated Financial Statement Detail
12 Months Ended
Dec. 31, 2017
Consolidated Financial Statement Detail [Abstract]  
Consolidated Financial Statement Detail

3. Consolidated Financial Statement Detail

Cash and Cash Equivalents

At December 31, 2017, cash and cash equivalents consisted of demand deposits of $34.9 million and money market funds of $8.6 million with maturities of less than 90 days at the date of purchase. At December 31, 2016, cash and cash equivalents consisted of demand deposits of $21.5 million and money market funds of $4.2 million with maturities of less than 90 days at the date of purchase.

Property and Equipment, net

Property and equipment, net consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Equipment and furniture

 

$

124

 

 

$

14,023

 

Leasehold improvements

 

 

 

 

 

554

 

 

 

 

124

 

 

 

14,577

 

Less:  Accumulated depreciation and amortization

 

 

(41

)

 

 

(13,541

)

Property and equipment, net

 

$

83

 

 

$

1,036

 

 

 

As of December 31, 2016, property and equipment held under capital leases, included under equipment and furniture above, amounted to $0.3 million, with accumulated amortization of $0.1 million. The Company terminated these capital lease equipment agreements in March 2017. Depreciation and amortization expense was $0.3 million, $0.8 million, and $1.5 million for the years ended December 31, 2017, 2016, and 2015, respectively.

 

During the year ended December 31, 2017, the Company completed the sale of equipment and disposal of other certain equipment located in one of its leased facilities for total proceeds of $1.6 million. The total carrying value of the equipment sold and disposed of was $0.4 million. Accordingly, the Company recorded a gain of $1.2 million on the sale and disposal of equipment on the other income (expense), net line of the Company’s consolidated statement of comprehensive income (loss).

In connection with the restructuring activities implemented in December 2016, the Company determined that the leasehold improvements located in one of its leased facilities are no longer expected to be used by the Company. The Company determined that an impairment charge equal to the net book value of the leasehold improvements of $0.2 million should be recorded as the future economic value, if any, that may be realized from the leasehold improvements would be negligible in a sublease transaction. The impairment charge is reflected within the restructuring charge in the consolidated statement of comprehensive income (loss) for the year ended December 31, 2016. During the year ended December 31, 2017, the Company recognized an impairment charge of $0.2 million related to one of its leased facilities. There were no significant impairment charges recognized during the year ended December 31, 2015.

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Accrued payroll and other benefits

 

$

141

 

 

$

1,582

 

Accrued clinical trial costs

 

 

 

 

 

458

 

Accrued incentive compensation

 

 

229

 

 

 

 

Accrued legal and accounting fees

 

 

431

 

 

 

385

 

Deferred rent

 

 

765

 

 

 

707

 

Liability related to sublease

 

 

800

 

 

 

 

Other

 

 

179

 

 

 

1,083

 

Total

 

$

2,545

 

 

$

4,215